. 2012 Nov 7;7(11):e46327. doi: 10.1371/journal.pone.0046327

Table 4. Unadjusted and adjusted risk ratios (95% CI)^a of factors associated with high score at follow-up time points in patients with late stage Parkinson and Parkinsonism's disease.

Predictor	Group	Outcome variable
		POS-PP		Core-POS		PDQ-8		HADs-14^b
		Unadjusted	Adjusted	Unadjusted	Adjusted	Unadjusted	Adjusted	Unadjusted	Adjusted
Baseline POS-PP	–	1.22 ^ (1.13 to 1.31)**	1.10(0.97 to 1.24)	1.12 (1.06 to 1.18) ^**	0.89 (0.81 to 0.99) ^*	1.11 (1.05 to 1.17) ^**	0.89 (0.81 to 0.99) ^*	1.04(0.99 to 1.10)	–
Baseline Core-POS	–	1.40 (1.23 to 1.60) ^**	1.30 (1.05 to 1.60) ^*	1.43 (1.25 to 1.63) ^**	1.52 (1.24 to 1.87) ^**	1.21 (1.09 to 1.34) ^**	1.52 (1.24 to 1.87) ^**	1.17 (1.05 to 1.30) ^**	1.10(0.97 to 1.25)
Baseline PDQ-8	–	1.09 (1.05to 1.13) ^**	1.02 (0.97 to 1.07)	1.08 (1.05 to 1.12) ^**	1.28 (1.09 to 1.51) ^**	1.14 (1.08 to 1.20) ^**	1.08 (1.03 to 1.14) ^**	1.04 (1.01 to 1.06) ^*	1.01(0.98 to 1.05)
Baseline HADs-14	–	1.22 (1.06 to 1.40) ^**	1.22 (1.02 to 1.46) ^*	1.24 (1.08 to 1.42) ^**	1.18 (1.01 to 1.38) ^*	1.15 (1.01 to 1.30) ^*	1.18(1.01 to 1.38)^*	1.27 (1.11 to 1.45) ^**	1.21 (1.06 to 1.39) ^**
Sex	Female vs Male	3.20 (1.22 o 8.35) ^*	5.19 (1.17 to 22.95) ^*	1.48(0.59 to 3.71)	–	1.16(0.45 to 2.97)	–	0.74(0.27 to 2.02)	–
Stage	Mild bilateral disease vs Wheel Chair	0.16 (0.04 to 0.56) ^**	0.18(0.02 to 1.46)	0.74(0.23 to 2.40)	–	0.23 (0.06 to 0.81) ^*	0.15(0.02 to 1.39)	3.38(0.92 to 12.39)	–
	Severe disability vs Wheel Chair	1.16(0.38 to 3.55)	1.10(0.23 to 5.23)	1.49(0.48 to 4.62)	–	0.87(0.28 to 2.77)	0.98(0.20 to 4.78)	3.12(0.87 to 11.21)	–

: Risk ratios were estimated using the ordinal logistic regression models, the risk ratio indicates how much more likely people with a risk factor are to have higher score in the follow-up assessment, where 1 indicates no risk in comparison to the reference group. The factors used to construct the models are showing in columns corresponding to individual outcome variables.

: Sample size n = 51, the modelling of other outcome variables were based on a sample size of 61.

Statistically significant effects (p<0.05) are in bold,

p<0.05,

^**

p<0.01.

Table 4. Unadjusted and adjusted risk ratios (95% CI)a of factors associated with high score at follow-up time points in patients with late stage Parkinson and Parkinsonism's disease.

Table 4. Unadjusted and adjusted risk ratios (95% CI)^a of factors associated with high score at follow-up time points in patients with late stage Parkinson and Parkinsonism's disease.